Form 4: InspireMD Executive Patrick Verta Reports Stock and Option Transactions

EVP Patrick Verta reports acquisition and disposal of InspireMD stock and options, including grants that vest over three years.

Summary

• Patrick Verta, EVP Clinical/Medical Affairs at InspireMD, Inc., filed a Form 4 detailing changes in beneficial ownership.
• On January 7, 2025, Verta acquired 83,072 shares of common stock and options to purchase 37,933 shares of common stock.
• The common stock is restricted and vests in three equal annual installments starting January 7, 2026, and continuing on January 7, 2027, and January 7, 2028, contingent upon continued service.
• The options also vest in three equal annual installments on the same dates as the stock.
• Verta disposed of 311,532 shares of common stock.
• Following these transactions, Verta beneficially owns 311,532 shares of common stock and 117,281 options.

Sentiment

Score: 5

Explanation: Neutral sentiment as it's a standard disclosure of insider transactions. The vesting schedule suggests a long-term commitment.

Future Outlook

The vesting schedule of the restricted stock and options indicates a multi-year commitment from the executive.

Industry Context

Form 4 filings are standard disclosures for company insiders and provide transparency into their transactions in the company's securities.

Stakeholder Impact

• Shareholders can monitor insider transactions for insights into management's perspective on the company's value.

Key Dates